XBIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Xenetic Biosciences Inc (XBIO) is not a strong buy for a beginner, long-term investor at this time. Despite some improvement in financial performance, the lack of significant trading trends, absence of positive news, and bearish technical indicators suggest that the stock does not currently present a compelling long-term investment opportunity.
The MACD is positive and expanding, which is a mildly bullish signal. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. The stock is trading near its pivot point of 2.251, with resistance at 2.419 and support at 2.083. Overall, the technical indicators suggest a weak trend with no clear upward momentum.
Revenue increased by 67.19% YoY in Q3 2025, and net income improved by 16.78% YoY, showing some financial growth.
No recent news or significant trading trends from hedge funds or insiders. The stock has a bearish moving average trend, and similar candlestick patterns suggest a slight decline in the short term (-0.22% next day, -0.42% next week, -0.4% next month).
In Q3 2025, revenue increased by 67.19% YoY to $1,026,957. Net income improved by 16.78% YoY to -$509,940, and EPS increased by 17.86% YoY to -0.33. Gross margin remained at 100%. Despite these improvements, the company is still operating at a loss.
No analyst rating or price target changes available.
